New drug tested for Tough-to-Treat skin cancer
Disease control
Completed
This early-stage study tested an investigational drug called PLX3397 in a small group of adults with advanced melanoma that had spread and could not be surgically removed. The cancer also had to have a specific genetic change called a KIT mutation. The main goals were to check th…
Phase: NA • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC